Increasing propellant gas emissions from pressurized metered-dose inhalers in obstructive lung diseases in France over 11 years

INTRODUCTION: ), contributing to climate change. The aim of this study was to estimate the carbon footprint of the propellant gases contained in all pressurized metered-dose inhalers prescribed in France, over an 11-year period. METHODS: equivalents based on their corresponding Global Warming Potential values. RESULTS: eq, representing a 38,7% increase, particularly pronounced since 2021. DISCUSSION: eq in 11 years, increasing annually. These findings highlight the substantial carbon footprint associated with current inhalers containing high Global Warming Potential propellant gases and underline the need to promote lower-impact therapeutic alternatives.

Authors

Institutions

Publication Details

Journal
Respiratory Research
Published
2026-04-16
DOI
https://doi.org/10.1186/s12931-026-03527-3
Primary Topic
Inhalation and Respiratory Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Increasing propellant gas emissions from pressurized metered-dose inhalers in obstructive lung diseases in France over 11 years

Grégoire Müller, David Grimaldi, Jade Mahé, Maéva Zysman et al.
Respiratory Research
Inhalation and Respiratory Drug Delivery
article

Increasing propellant gas emissions from pressurized metered-dose inhalers in obstructive lung diseases in France over 11 years

Grégoire Müller, David Grimaldi, Jade Mahé, Maéva Zysman, Maxime Patout, Arnaud Bourdin, Nicolas Roche
article en

Abstract

INTRODUCTION: ), contributing to climate change. The aim of this study was to estimate the carbon footprint of the propellant gases contained in all pressurized metered-dose inhalers prescribed in France, over an 11-year period. METHODS: equivalents based on their corresponding Global Warming Potential values. RESULTS: eq, representing a 38,7% increase, particularly pronounced since 2021. DISCUSSION: eq in 11 years, increasing annually. These findings highlight the substantial carbon footprint associated with current inhalers containing high Global Warming Potential propellant gases and underline the need to promote lower-impact therapeutic alternatives.

Respiratory ResearchVol. 27(1)
Université de Tours (FR), Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), Inserm (FR), Université Paris Cité (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Sorbonne Université (FR), Hôpital Cochin (FR), Assistance Publique – Hôpitaux de Paris (FR), Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale (FR), Institut Cochin (FR), Centre hospitalier universitaire d'Orléans (FR), Hôpital Arnaud de Villeneuve (FR), Centre de Recherche Cardio-Thoracique de Bordeaux (FR), French Clinical Research Infrastructure Network (FR)
Openalex Percentile: Top 23%
Inhalation and Respiratory Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.